3-AP
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for 3-AP, covering 2010-03-10 to 2023-08-04. Get the full timeline:
Most recent: Clinical Trial Update: 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma [Phase 2]